Sagimet Biosciences
A biopharmaceutical company developing therapeutics for the treatment of infectious diseases.
Launch date
Employees
Market cap
$120m
Enterprise valuation
($46m) (Public information from Sep 2024)
Share price
$3.28 SGMT
San Mateo California (HQ)
Authorizing premium user...